课题基金 / 基金详情

Human Immunology Spondyloarthritis Team (HUMISPOT) studying immunopathogenesis, disease heterogeneity and drug discovery in spondyloarthritis

Human Immunology Spondyloarthritis Team (HUMISPOT) studying immunopathogenesis, disease heterogeneity and drug discovery in spondyloarthritis
人类免疫学脊柱关节炎团队 (HUMISPOT) 研究脊柱关节炎的免疫发病机制、疾病异质性和药物发现
批准号:
395724
负责人:
Haroon Nigil
金额:
$1.46万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-10-01 至 2019-10-01

项目摘要

项目成果

Haroon Nigil的其他基金

相似基金

相关文献

中文摘要
翻译
脊椎关节炎(SpA)是一种常见的关节炎,对加拿大人的生活质量和加拿大医疗保健系统的成本有重大影响。我们是一个合作团队,汇集了风湿病专家的专业知识
英文摘要
Spondyloarthritis (SpA) is a common form of arthritis with significant impact on quality of life for individual Canadians and for costs to the Canadian health care system. We are a collaborative team that brings together rheumatologists with expertise in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIF1-alpha interacts with MIF to drive inflammation and new bone formation in spondyloarthritis
  • 批准号:
    445586
  • 项目类别:
    Operating Grants
  • 资助金额:
    $48.49万
  • 财政年份:
    2021
  • 负责人:
    Haroon Nigil
  • 依托单位:
Therapeutic Targeting of MIF in a Spondyloarthritis Mouse Model
  • 批准号:
    381460
  • 项目类别:
    Operating Grants
  • 资助金额:
    $22.01万
  • 财政年份:
    2018
  • 负责人:
    Haroon Nigil
  • 依托单位:
Personalized medicine for ankylosing spondylitis
  • 批准号:
    365355
  • 项目类别:
    Operating Grants
  • 资助金额:
    $14.57万
  • 财政年份:
    2017
  • 负责人:
    Haroon Nigil
  • 依托单位:
Definitive treatment of AS by blocking Macrophage Migration Inhibitory Factor (MIF)
  • 批准号:
    351879
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Haroon Nigil
  • 依托单位:
海外基金